ZERO Outraged Docs Don't Offer Solution In PSA Crisis
July 02, 2017
A new study of the effectiveness of the PSA test for prostate cancer is yet another claim prostate cancer screening has little to no value in lowering the death rate with offering no solutions to the problem.
While this most recent study, published in the New England Journal of Medicine, casts a blanket statement about prostate cancer screening, it fails to address those individuals who are in high risk groups like African-Americans and those with a family history of the disease as well as those men who will have rapidly growing tumors.
The patient advocate community stands together in calling for immediate increases in prostate cancer research funding for early detection such as imaging technologies and biomarkers that will more accurately detect prostate cancer and correctly gauge its severity.
We believe the PSA test has contributed to a drop in the death rate over the past two decades. Still, more than 28,000 will die needlessly this year to this scourge because education outreach and improvements in early detection continue to fall short.
Now is the time for all men at risk for prostate cancer and their loved ones to stand with us and demand action in this crisis.
About ZERO - The Project to End Prostate Cancer (ZeroCancer)
Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. Our name conveys what we stand for - zero tolerance for prostate cancer.
At ZERO, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
ZERO
ZeroCancer